Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eugenio Gallo

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Molecular Biotechnology|April 10, 2019
A High-Throughput Platform for the Generation of Synthetic Ab Clones by Single-Strand Site-Directed MutagenesisEugenio Gallo
Molecular Biotechnology|January 3, 2020
High-Throughput Generation of In Silico Derived Synthetic Antibodies via One-step Enzymatic DNA Assembly of FragmentsEugenio Gallo
Molecular Biology Reports|January 18, 2024
Current advancements in B-cell receptor sequencing fast-track the development of synthetic antibodiesEugenio Gallo
Journal of Biomedical Science|March 16, 2024
The rise of big data: deep sequencing-driven computational methods are transforming the landscape of synthetic antibody designEugenio Gallo
Bioconjugate Chemistry|December 3, 2019
Fluorogen-Activating Proteins: Next-Generation Fluorescence Probes for Biological ResearchEugenio Gallo
Molecular Biotechnology|February 3, 2024
Revolutionizing Synthetic Antibody Design: Harnessing Artificial Intelligence and Deep Sequencing Big Data for Unprecedented AdvancesEugenio Gallo
Molecular Biology Reports|July 5, 2020
Critical role of EphA3 in cancer and current state of EphA3 drug therapeuticsMax London, Eugenio Gallo
Molecular Biology Reports|September 29, 2020
The EphA2 and cancer connection: potential for immune-based interventionsMax London, Eugenio Gallo
Cell Biology International|March 13, 2020
Epidermal growth factor receptor (EGFR) involvement in epithelial-derived cancers and its current antibody-based immunotherapiesMax London, Eugenio Gallo
Molecular Biotechnology|February 25, 2014
Fluorogen-activating scFv biosensors target surface markers on live cells via streptavidin or single-chain avidinEugenio Gallo, Jonathan Jarvik
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Molecular Biotechnology|April 10, 2019
A High-Throughput Platform for the Generation of Synthetic Ab Clones by Single-Strand Site-Directed MutagenesisEugenio Gallo
Molecular Biotechnology|January 3, 2020
High-Throughput Generation of In Silico Derived Synthetic Antibodies via One-step Enzymatic DNA Assembly of FragmentsEugenio Gallo
Molecular Biology Reports|January 18, 2024
Current advancements in B-cell receptor sequencing fast-track the development of synthetic antibodiesEugenio Gallo
Journal of Biomedical Science|March 16, 2024
The rise of big data: deep sequencing-driven computational methods are transforming the landscape of synthetic antibody designEugenio Gallo
Bioconjugate Chemistry|December 3, 2019
Fluorogen-Activating Proteins: Next-Generation Fluorescence Probes for Biological ResearchEugenio Gallo
Molecular Biotechnology|February 3, 2024
Revolutionizing Synthetic Antibody Design: Harnessing Artificial Intelligence and Deep Sequencing Big Data for Unprecedented AdvancesEugenio Gallo
Molecular Biology Reports|July 5, 2020
Critical role of EphA3 in cancer and current state of EphA3 drug therapeuticsMax London, Eugenio Gallo
Molecular Biology Reports|September 29, 2020
The EphA2 and cancer connection: potential for immune-based interventionsMax London, Eugenio Gallo
Cell Biology International|March 13, 2020
Epidermal growth factor receptor (EGFR) involvement in epithelial-derived cancers and its current antibody-based immunotherapiesMax London, Eugenio Gallo
Molecular Biotechnology|February 25, 2014
Fluorogen-activating scFv biosensors target surface markers on live cells via streptavidin or single-chain avidinEugenio Gallo, Jonathan Jarvik
Pageof 4